Search
Search - News - Store - Contact

RPMI 1640 was developed by Moore and his co-workers at Roswell Park Memorial Institute in 1966 for the growth of human leukemia cells in monolayer or suspension cultures.

RPMI Media are "multipurpose" enriched media providing extensive applications for a broad spectrum of mammalian and hybridoma cells including:

  • Human myeloma
  • Mouse hybridoma
  • Human leukocytes
  • B and T lymphocytes
     
  • Discover the complete range of Biowest RPMI 1640:


  1   2   >   >>